Immunooncology

Immuno-oncology is a type of immunotherapy that is specifically targeted to fight cancer. Immuno-oncology works by stimulating our immune system to fight back, when it wouldn’t usually be able to. Normally, our immune system is able to destroy cancer cells in our body, however sometimes cancer cells can adapt and mutate, effectively hiding from our immune system. This is when tumours can develop and become a threat to our health. Immuno-oncology involves mobilising lymphocytes to recognise and eliminate cancer cells using the body’s immune system. Our immune system is a complex network of organs, cells and molecules that protects us from foreign substances—such as bacteria and viruses—that can cause infection. In addition to finding and destroying foreign substances, the immune system can also locate and attack abnormal cells. Immuno-oncology allows cancer cells to be targeted, leaving the rest of the body unharmed. It also has far fewer limitations, being applicable to tumours at all stages of the disease with much higher efficiency and durability.

 

    Related Conference of Immunooncology

    April 04-05, 2024

    38th International Conference on Immunology

    Madrid, Spain
    May 23-24, 2024

    18th International Conference on European Immunology

    Zurich, Switzerland

    Immunooncology Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in